4108
J. Hermeke, P.H. Toy / Tetrahedron 67 (2011) 4103e4109
(t, J¼8.7 Hz, ArH, 2H), 6.67 (d, J¼2.3 Hz, ArH, 1H), 6.31 (s, NH, 1H),
2.32 (s, CH3, 3H), 2.02 (s, CH3, 3H); 13C NMR (126 MHz, CD3Cl):
126.6, 122.4, 121.7, 119.7, 119.5, 118.5, 111.3, 62.6, 45.7, 37.9, 14.0;
HRMS for C20H19NO3: calcd 321.1365, found 321.1356; HPLC con-
dition: IPA/hexane¼10:90, flow rate¼1.0 mL/min, AD-H column,
major 22.5 min, minor 28.4 min.
d
169.3 (s, 1C), 161.7 (d, J¼246 Hz, 1C), 141.0 (d, J¼2.9 Hz, 1C), 137.1
(s, 1C), 128.0 (s, 1C), 127.9 (s, 1C), 124.6 (s, 1C), 122.9 (d, J¼11.8 Hz,
2C), 122.4 (s, 1C), 120.2 (s, 1C), 120.0 (s, 1C), 114.9 (d, J¼21.4 Hz, 2C),
111.8 (s, 1C), 58.9 (s, 1C), 26.7 (s, 1C), 24.4 (s, 1C); HRMS for
4.3.2.2. 4-(1H-Indol-3-yl)-2-oxo-4-(4-methylphenyl)butyric acid
C
18H17FN2O: calcd 296.1325, found 296.1319; HPLC condition: IPA/
ethyl ester (11b). This was obtained in 94% yield and 50% ee. 1H
hexane¼10:90, flow rate¼1.0 mL/min, AD-H column, minor
NMR (400 MHz, CD3Cl):
d
8.01 (s, NH, 1H), 7.43 (d, J¼7.9 Hz, ArH,
18.7 min, major 23.7 min.
1H), 7.30 (d, J¼8.1 Hz, ArH, 1H), 7.20 (d, J¼8.0 Hz, ArH, 2H), 7.15 (t,
J¼7.8 Hz, ArH, 1H), 7.07e7.00 (m, ArH, 4H), 4.88 (t, J¼7.5 Hz, CH, 1H),
4.20 (dq, J¼1.1, 4.1 Hz, CH2, 2H), 3.63 (dd, J¼7.3, 18.9 Hz, CHaHb, 1H),
3.59 (dd, J¼7.3, 18.9 Hz, CHaHb, 1H), 2.27 (s, CH3, 3H), 1.26 (t,
4.3.1.4. N-(1-(3-Indolyl)-1-(4-methoxyphenyl)ethyl)acetamide
(9d). This was obtained in 65% yield and 61% ee. 1H NMR (300 MHz,
CD3Cl):
d
8.08 (s, NH, 1H), 7.49 (d, J¼8.1 Hz, ArH, 1H), 7.38e7.32 (m,
J¼7.1 Hz, CH3, 3H); 13C NMR (126 MHz, CD3Cl):
d 193.3, 161.2, 140.3,
ArH, 3H), 7.19 (t, J¼7.5 Hz, ArH, 1H), 7.06 (t, J¼7.4 Hz, ArH, 1H), 6.86
(d, J¼8.8 Hz, ArH, 2H), 6.74 (d, J¼2.4 Hz, ArH, 1H), 6.27 (s, NH, 1H),
3.80 (s, MeO, 3H), 2.31 (s, CH3, 3H), 2.01 (s, CH3, 3H); 13C NMR
136.7, 136.2, 129.4, 127.8, 126.6, 122.4, 121.6, 119.6, 119.6, 118.7, 111.3,
62.6, 45.9, 37.6, 21.1, 14.0; HRMS for C21H21NO3: calcd 335.1521,
found 335.1521; HPLC condition: IPA/hexane¼10:90, flow
rate¼1.0 mL/min, AD-H column, major 22.2 min, minor 30.3 min.
(126 MHz, CD3Cl):
d 169.3, 158.3, 137.7, 137.1, 129.2, 127.4, 124.8,
123.1, 122.7, 122.1, 120.3, 119.7, 113.5, 113.5, 111.7, 58.9, 55.3, 26.8,
24.5; HRMS for C19H20N2O2: calcd 308.1525, found 308.1524; HPLC
condition: IPA/hexane¼17:83, flow rate¼1.0 mL/min, AS-H column,
major 14.7 min, minor 20.3 min.
4.3.2.3. 4-(1H-Indol-3-yl)-2-oxo-4-(4-bromophenyl)butyric acid
ethyl ester (11c). This was obtained in 92% yield and 60% ee. 1H
NMR (400 MHz, CD3Cl):
d 8.04 (s, NH, 1H), 7.40e7.32 (m, ArH, 4H),
7.21e7.15 (m, ArH, 3H), 7.05e7.01 (m, ArH, 2H), 4.87 (t, J¼7.5 Hz, CH,
1H), 4.24 (dq, J¼0.6, 7.1 Hz, CH2, 2H), 3.65 (dd, J¼7.0, 12.1 Hz, CHaHb,
1H), 3.56 (dd, J¼8.0, 12.6 Hz, CHaHb, 1H), 1.29 (t, J¼7.1 Hz, CH3, 3H);
4.3.1.5. N-(1-(5-Bromo-3-indolyl)-1-phenylethyl)acetamide
(9e). This was obtained in 83% yield and 89% ee. 1H NMR (400 MHz,
CD3Cl):
d
8.29 (s, NH, 1H), 7.53 (s, ArH, 1H), 7.38e7.31 (m, ArH, 4H),
13C NMR (126 MHz, CD3Cl):
d 192.7, 160.9, 142.3, 136.6, 131.6, 129.6,
7.29e7.28 (m, ArH, 1H), 7.24 (dd, J¼8.6, 1.8 Hz, ArH, 1H), 7.17 (d,
126.2, 122.5, 121.5, 120.4, 119.7, 119.3, 117.9, 111.2, 62.6, 45.3, 37.2,
13.9; HRMS for C20H18BrNO3: calcd 399.0470, found 399.0464;
HPLC condition: IPA/hexane¼10:90, flow rate¼1.0 mL/min, AD-H
column, major 23.2 min, minor 38.4 min.
J¼8.6 Hz, ArH, 1H), 6.78 (d, J¼2.6 Hz, ArH, 1H), 6.21 (s, NH, 1H), 2.28
(s, CH3, 3H), 2.04 (s, CH3, 3H); 13C NMR (126 MHz, CD3Cl):
d 169.4,
145.2, 135.7, 128.4, 127.2, 126.7, 126.1, 125.0, 124.5, 122.7, 121.5, 113.1,
112.9, 59.1, 27.2, 24.5; HRMS for C18H17BrN2O: calcd 356.0524,
found 356.0502; HPLC condition: IPA/hexane¼10:90, flow
rate¼1.0 mL/min, AD-H column, minor 17.3 min, major 35.4 min.
4.3.2.4. 4-(1H-Indol-3-yl)-2-oxo-4-(4-methoxyphenyl)butyric
acid ethyl ester (11d). This was obtained in 89% yield and 50% ee. 1H
NMR (400 MHz, CD3Cl):
d
8.02 (s, NH, 1H), 7.41 (d, J¼7.9 Hz, ArH,
4.3.1.6. N-(1-(5-Flouro-3-indolyl)-1-phenylethyl)acetamide
1H), 7.31 (d, J¼8.1 Hz, ArH, 1H), 7.20 (d, J¼8.5 Hz, ArH, 2H), 7.15 (t,
J¼7.5 Hz, ArH, 1H), 7.07e7.01 (m, ArH, 2H), 6.79 (d, J¼8.5 Hz, ArH,
2H), 4.86 (t, J¼7.5 Hz, CH, 1H), 4.24 (q, J¼6.9 Hz, CH2, 2H), 3.75 (s,
eOCH3, 3H), 3.64 (dd, J¼7.2, 16.7 Hz, CHaHb, 1H), 3.57 (dd, J¼8.0,
16.7 Hz, CHaHb, 1H), 1.27 (t, J¼7.0 Hz, CH3, 3H); 13C NMR (101 MHz,
(9f). This was obtained in 80% yield and 58% ee. 1H NMR (500 MHz,
CD3Cl):
d
8.07 (s, NH, 1H), 7.39e7.36 (m, ArH, 2H), 7.33 (t, J¼7.6 Hz,
ArH, 3H), 7.30e7.28 (m, ArH, 1H), 7.04 (dd, J¼2.0, 9.0 Hz, ArH, 1H),
6.93 (dt, J¼2.5, 9.0 Hz, ArH, 1H), 6.87 (d, J¼2.5 Hz, ArH, 1H), 6.19 (s,
NH, 1H), 2.30 (s, CH3, 3H), 2.03 (s, CH3, 3H); 13C NMR (126 MHz,
CD3Cl):
d 193.4, 161.1, 158.3, 136.7, 135.5, 135.5, 128.9, 126.6, 122.4,
CD3Cl):
d
169.3 (s, 1C), 157.6 (d, J¼230 Hz, 1C), 145.2 (s, 1C), 133.5 (s,
121.5, 119.6, 119.6, 118.9, 114.0, 111.3, 62.6, 55.6, 45.9, 37.2, 14.0;
HRMS for C21H21NO4: calcd 351.1471, found 351.1467; HPLC condi-
tion: IPA/hexane¼17:83, flow rate¼1.0 mL/min, AS-H column, ma-
jor 15.3 min, minor 17.9 min.
1C), 130.9 (d, J¼3.0 Hz, 1C), 128.8 (s, 1C), 128.4 (s, 2C), 127.1 (s, 1C),
126.1 (s, 1C),124.8 (s, 2C),112.3 (d, J¼9.7 Hz,1C),110.6 (d, J¼26.6 Hz,
1C), 105.3 (d, J¼24.2 Hz, 1C), 59.2 (s, 1C), 26.8 (s, 1C), 24.5 (s, 1C);
HRMS for C18H17FN2O: calcd 296.1325, found 296.1320; HPLC
condition: IPA/hexane¼10:90, flow rate¼1.0 mL/min, AD-H column
minor 18.5 min, major 30.6 min.
4.3.2.5. 4-(1H-5-Bromoindol-3-yl)-2-oxo-4-phenylbutyric
ethyl ester (11e). This was obtained in 90% yield and 46% ee. 1H
NMR (400 MHz, CD3Cl): 8.08 (s, NH, 1H), 7.53 (s, ArH, 1H),
acid
d
4.3.2. General procedure for FriedeleCrafts Reaction of indoles with
7.31e7.24 (m, ArH, 4H), 7.22e7.17 (m, ArH, 3H), 7.05 (d, J¼2.0 Hz,
ArH, 1H), 4.85 (t, J¼7.5 Hz, CH, 1H), 4.23 (dq, J¼1.0, 8.4 Hz, CH2, 2H),
3.64 (dd, J¼7.6, 17.1 Hz, CHaHb, 1H), 3.56 (dd, J¼7.6, 17.0 Hz, CHaHb,
1H), 1.28 (t, J¼7.1 Hz, CH3, 3H); 13C NMR (101 MHz, CD3Cl): 193.0,
161.0, 142.9, 135.3, 128.8, 128.3, 127.8, 126.9, 125.4, 122.9, 122.0,
118.1, 113.0, 112.8, 62.7, 45.7, 37.7, 14.1; HRMS for C20H18BrNO3:
calcd 399.0470, found 399.0464; HPLC condition: IPA/
hexane¼10:90, flow rate¼1.0 mL/min, AD-H column, major
16.8 min, minor 20.6 min.
b,
g
-unsaturated
a-keto esters (Table 2). Phosphoric acid catalyst
(R)-17 (5.5 mg, 0.005 mmol, 5 mol %),
b
,
g
-unsaturated -keto ester
a
ꢀ
10 (0.07 mmol,1.0 equiv) and 4 A MS (90 mg) were added to a flame
dried Schlenk tube under a N2 atmosphere, followed by dry CH2Cl2
(1.0 mL). The reaction mixture was then cooled to ꢁ78 ꢀC and in-
dole 7 (0.15 mmol, 2.1 equiv) was added. After TLC analysis in-
dicated that the reaction was completed, the reaction mixture was
purified directly by chromatography (20% ethyl acetate/hexane) to
afford product 11.
4.3.2.6. 4-(1H-5-Flouroindol-3-yl)-2-oxo-4-phenylbutyric
ethyl ester (11f). This was obtained in 92% yield and 54% ee. 1H NMR
(400 MHz, CD3Cl): 8.07 (s, NH, 1H), 7.29e7.19 (m, ArH, 6H),
acid
4.3.2.1. 4-(1H-Indol-3-yl)-2-oxo-4-phenylbutyric acid ethyl ester
(11a). This was obtained in 98% yield and 61% ee. 1H NMR
d
(400 MHz, CD3Cl):
d
8.01 (s, NH, 1H), 7.42 (d, J¼8.0 Hz, ArH, 1H), 7.32
7.07e7.02 (m, ArH, 2H), 6.88 (t, J¼7.5 Hz, ArH, 1H), 4.83 (t, J¼7.3 Hz,
CH, 1H), 4.22 (q, J¼6.8 Hz, CH2, 2H), 3.65 (dd, J¼7.5, 16.9 Hz, CHaHb,
1H), 3.56 (dd, J¼7.5, 16.9 Hz, CHaHb, 1H), 1.28 (t, J¼7.1 Hz, CH3, 3H);
(t, J¼6.8 Hz, ArH, 3H), 7.26 (t, J¼7.5 Hz, ArH, 2H), 7.15 (q, J¼6.0 Hz,
ArH, 2H), 7.02 (t, J¼7.5 Hz, ArH, 2H), 4.91 (t, J¼7.5 Hz, CH, 1H), 4.20
(dq, J¼1.2, 5.6 Hz, CH2, 2H), 3.67 (dd, J¼7.4, 16.9 Hz, CHaHb, 1H), 3.59
(dd, J¼7.4, 16.9 Hz, CHaHb, 1H), 1.26 (t, J¼7.1 Hz, CH3, 3H); 13C NMR
13C NMR (101 MHz, CD3Cl):
d 193.1 (s, 1C), 161.1 (s, 1C), 157.7 (d,
J¼230 Hz, 1C), 143.0 (s, 1C), 133.2 (s, 1C), 128.8 (s, 2C), 127.8 (s, 2C),
(126 MHz, CD3Cl):
d 193.2, 161.1, 143.4, 136.7, 128.7, 127.9, 126.7,
127.0 (s, 1C), 126.9 (s, 1C), 123.4 (s, 1C), 118.6 (d, J¼3.5 Hz, 1C), 111.9